Laser Process Development Engineer 2

Confluent Medical Technologies, a medical device contract manufacturer specialising in Nitinol and polymer components, has appointed Tom Testa as chief operating officer, effective 29 April 2026. In his role, Testa will oversee global operations, supply chain, product development and environmental health and safety. Testa joins from Corza Medical, where he served as CEO and CFO. He previously held positions as vice president and general manager at Nordson Medical and president at Vention Medical Advanced Technologies. He holds a bachelor's degree in chemical engineering from New Jersey Institute of Technology and an MBA in finance from New York University. Confluent operates facilities across the United States, Costa Rica and India, providing catheter-based devices and implants to medical device manufacturers.

Confluent Medical Technologies names Tom Testa as Chief Operating Officer. GlobeNewswire | Confluent Medical Technologies Today at 9:30am PDT SCOTTSDALE, Ariz., May 01, 2026 (GLOBE NEWSWIRE) - Confluent Medical Technologies, Inc. ("Confluent"), a leading medical device and materials science contract manufacturer specializing in Nitinol and polymer components, today announced that Tom Testa, has been appointed as Chief Operating Officer ("COO") for the company, effective April 29th, 2026. "We are thrilled to welcome Tom to Confluent," said Dean Schauer, Confluent's President, CEO, and Chairman. "Tom has exceptional experience in all aspects of Executive Leadership in the Medical Device Manufacturing and Development space as well as leadership across multiple, successful, MedTech organizations. As Confluent continues its significant growth, the addition of Tom to our company will further enhance the strength of our industry-leading team." As COO, Mr. Testa's responsibilities will span global operations, and he will oversee Confluent's operations, supply chain, global product development, and environmental health & safety. Mr. Testa joins Confluent from Corza Medical where he served as CEO and CFO. Prio to that, Tom served as Vice President & General Manager of the Nordson Medical business which he joined following the acquisition of the Vention Medical Advanced Technologies Business where he served as President. Tom holds a Bachelor of Science degree in Chemical Engineering from New Jersey Institute of Technology as well as an MBA in Finance from New York University. Commenting on his appointment, Mr. Testa said: "I'm excited to join Confluent at such a pivotal moment in its growth. The company has built a strong reputation as a trusted partner to leading medical device innovators, grounded in its differentiated materials science expertise and vertically integrated manufacturing capabilities. I look forward to working with this talented team to further strengthen operational excellence, expand our global footprint, and help drive the next phase of sustainable growth for our customers and the patients they serve." About Confluent Medical Technologies, Inc.: Confluent Applies Materials Science to MedTech Innovation. Confluent specializes in the expert design, development, and large-scale manufacturing of interventional catheter-based devices and implants. Customers rely on Confluent's expertise in Nitinol material and components, balloon and complex catheters, high-precision polymer tubing, and implantable textiles. With facilities in Fremont and Orange County, California; Warwick, Rhode Island; Windham, Maine; Austin, Texas; Chattanooga, Tennessee; San Jose, Costa Rica; and Hyderabad, India, Confluent has earned the confidence of the leaders in the medical device community through a proven track record of innovative materials science, engineering, and manufacturing. For more information, visit confluentmedical.com. This is a paid placement. For further inquiries, please contact GlobeNewswire directly.

Confluent introduces customizable PTFE and polyimide tubing for medical devices. New program lets OEMs choose specific polymer characteristics for advanced medical applications, moving beyond standard materials. Tubing options in the Filmcast Select program include standard, REACH-compliant glossy and matte, and Ultra polyimides. Confluent Medical Technologies One size almost never fits all, and that's true in the material selection process, as well. To give medical device OEMs more control over the properties of polymer tubing they are sourcing, Confluent Medical Technologies has launched Filmcast Select. The materials customization program allows customers to select key performance attributes of Filmcast PTFE and polyimide tubing, the company said in the Jan. 28 announcement. Material selection process must adapt to medical device complexity. The standard Filmcast polymer tubing process offers little to no customization for device manufacturers, said Confluent, and as procedures become less invasive and devices become smaller and more complex, the one-size-fits-all approach is no longer sufficient. Filmcast Select addresses this shift by enabling OEMs to select Filmcast PTFE and polyimide tubing based on the characteristics that matter most in their applications, including flexibility, strength, durability, surface finish, regulatory compliance, and optical clarity. "Designing next-generation medical devices requires precision at every level, including material selection," said Director of Polymers Technology Shane Wood. "Filmcast Select gives our customers the ability to match material performance to device intent, rather than adapting their designs to standard materials." Wide selection of material properties. Multiple polyimide tubing options are available, including standard, REACH-compliant glossy and matte, and Ultra polyimides. Material properties range from high transparency and reduced friction to stronger bonding. The tensile strength of Ultra polyimide is nearly double that of the standard material in thin-wall designs, added Confluent. The program also features a range of Filmcast PTFE options, including FlexaCast for increased flexibility and elongation, DuraCast for enhanced abrasion resistance, and UltraCast for higher tensile strength in demanding applications. Confluent Medical said it can also work with customer-preferred PTFE dispersions, allowing OEMs to leverage existing biocompatibility data and reduce development time for new or next-generation devices. On show at MD&M West. The company will showcase this new service and related materials expertise at MD&M West in booth 1812. MD&M West is a comprehensive manufacturing-focused trade show and conference for the medical technology, plastics, packaging, and automation sectors. It runs from Feb. 3 to 5, 2026, at the Anaheim Convention Center in Anaheim, CA. Headquartered in Scottsdale, AZ, Confluent operates facilities across the United States as well as in Costa Rica and India. Experience cutting-edge product solutions and global networking at the Plastics Manufacturing Sector, previously Plastec West. Connect with top companies in 3D Printing, Injection Molding, Coatings, Furnishing, and more, as they showcase the latest biocompatible polymers and injection molding innovations.